Revolutionizing The Industry 4.0 Revolution - March 2021 (OTC:SCTC) - ScoutCam
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
(OTC:SCTC) Revolutionizing The Industry 4.0 Revolution March 2021
Disclaimer
This presentation includes statements that constitute forward-looking laws and political and economic instability in each jurisdiction.
statements within the meaning of safe harbor provisions of the Private
We cannot guarantee future results, levels of activity, performance or
Securities Litigation Reform Act of 1995 relating to future events or our
achievements. The matters discussed in this presentation also involve risks
future performance. Forward-looking statements involve known and
and uncertainties summarized under the heading “Risk Factors” in
unknown risks, uncertainties and other factors that may cause our actual
ScoutCam Inc.’s (i) most recent quarterly report on Form 10-Q as filed with
results, levels of activity, performance or achievements to be materially
the Securities and Exchange Commission (the “Commission”) on
different from any future results, levels of activity, performance or
November 12, 2020, and (ii) annual report on Form 10-K as filed with the
achievements expressed or implied in those forward- looking statements.
Commission on March 16, 2020. These factors are updated from time to
You should not place undue reliance on forward-looking statements since
time through the filing of reports and registration statements with the
they involve known and unknown risks, uncertainties and other factors
Commission. Any forward-looking statements contained in this
which are in some cases beyond our control. Factors that may affect our
presentation are made as of the presentation date and ScoutCam Inc. is
results, performance, circumstances or achievements include, but are not
under no obligation to revise or update these forward-looking statements.
limited to the following: (i) market acceptance of our existing and new
products, (ii) lengthy product delays in key markets, (iii) an inability to This presentation is being made exclusively to “accredited investors” as
secure regulatory approvals for the sale of our products, (iv) intense defined in Regulation D under the U.S. Securities Act of 1933, as amended
competition in the medical device and related industries from much larger, (the "Securities Act") and “qualified investors” under the First Addendum of
multinational companies, (v) product liability claims, (vi) product the Israeli Securities Law of 1968 (the “Securities Law”). The securities
malfunctions, (vii) our limited manufacturing capabilities and reliance on described herein have not been registered under the Securities Act and
third-parties for assistance, (viii) our efforts to successfully obtain and may not be offered or sold in the United States except pursuant to an
maintain intellectual property protection covering our products, which exemption from, or transaction not subject to, the registration
may not be successful, (ix) legislative or regulatory reform of the healthcare requirements of the Securities Act.
system in both the U.S. and foreign jurisdictions, (x) our reliance on single This document does not constitute an offer to sell, or a solicitation of an
suppliers for certain product components, (xi) the fact that we will need to offer to purchase, any securities in any jurisdiction where such offer or sale
raise additional capital to meet our business requirements in the future is not permitted. Any purchaser of such securities will be deemed to have
and that such capital raising may be costly, dilutive or difficult to obtain made certain representations and acknowledgments, including, without
and (xii) the fact that we conduct business in multiple foreign jurisdictions, limitation, that the purchaser is a “accredited investor” as defined in
exposing us to foreign currency exchange rate fluctuations, logistical and Regulation D under the Securities Act and a “qualified investor” under the
communications challenges, burdens and costs of compliance with foreign First Addendum of the Securities Law.
2
The right time to invest is now!
Micro-video cameras with High potential in medical, Blue ocean – SMART
Endurance and data aerospace and defense technologies to enhance
transfer capabilities in markets Industry 4.0
extremely harsh conditions
Innovative resilient Strong IP portfolio Strong investors and
miniature deep understanding of management experienced
Camera-as-a-SensorTM and experience in diverse in leading companies to
applications sustainable growth
3
Leading investors see an
impressive potential
My decision to formally join the ScoutCam
board reflects my growing belief in this company
and its potential, including beyond visualization
solutions for the medical industry.
ScoutCam, in my mind, has only begun to tap
into its vast potential, and that the applications
of its technology are limitless, whether in the
Mori Arkin fields of maintenance and predictive
Founder & Chairman maintenance, a critical pillar of Industry 4.0,
Arkin Holdings aviation and defense, and more.
I am excited to take a more active role on the
company’s leadership team to help realize this
impressive potential.“
https://finance.yahoo.com/news/leading-life-science-pharmaceutical-entrepreneur-140000961.html?guccounter=1 4
ScoutCam Founded on
March 1, 2019
Based on
a technology
10 years
and $20M
at a glance developed by
Medigus
R&D invested in
technology
Currently a global World record Our solutions
leader in custom- for the are highly
tailored micro- smallest diameter resilient to
visualization camera with extreme
solutions for a illumination = 1 mm conditions
variety of
industries
5
Micro-visualization solutions
customized for extra-ordinary conditions and applications
• Almost a decade in outer-space • Medial market leader chose ScoutCam
• 2nd & 3rd generation robotic to develop and produce a critical
refueling mission miniature visualization solution
• Included in the recommended • Product development completed
supplier database of the US • Our solution is included in a
Government revolutionary minimally invasive
• Invited supplier for the first surgical procedure
human mission to Mars • Two additional product development
projects are in progress
ScoutCam’s visualization solution Monitoring uranium rods in
installed in the robotic remote nuclear reactor cooling
inspection system for jet engine chambers in harsh radiation
NDT on aircraft wings conditions
6
Proven successes
in outer-space
ScoutCam’s micro 8.0 HD in NASA’s
3rd generation Robotic Refueling
Mission (RRM3), officially used in-orbit
on October 2020.
ScoutCam’s miniature cameras are
proven as highly resilient not only
under laboratory conditions, but also in
working for four consecutive days in
the harsh environment of outer-space.
Credits: NASA 7
From Medical Applications to Revolutionizing
the Industry 4.0 Revolution
New applications New relevant Revolutionizing
• Monitoring and markets the emerging,
maintenance • Aerospace disruptive field of
Industry 4.0 by
• Predictive • Defense
using ScoutCam’s
maintenance • Energy Camera-as-a-
Thanks to • Automotive SensorTM approach
• Size …and more
• Lightweight
• Endurance
8
The fourth industrial Industry 4.0
revolution is now! Market size
The Fourth Industrial Revolution (or Industry 4.0) is the
ongoing automation of traditional manufacturing and $210B
industrial practices, using modern smart technology. by 2026, growing at a
M2M CAGR of 17%(1)
(machine to
machine comm.)
IoT Increased efficiency
(Internet of & safety
Things)
AI
(artificial
intelligence)
Reduced costs
Big (OPEX)
data
9
1. Facts & Factors, Globe News Wire, 2020
Industry 4.0 accelerated due to COVID-19
Social distancing caused a shift toward remote, automated technologies(1)
IoT – Data from Remote access vs. Automation rather
diverse sensors on-site presence than manual work
SMART
Sensors Monitoring Automation Real-Time
1 https://www.supplychaindive.com/news/robots-automation-social-distancing-pandemic/581531/ 10Industry 4.0 applications’
SMART requirements:
disruption of
Introducing micro
the Industry 4.0 Camera-as-a-sensorTM as part of
an IoT system for complete vision
market
Providing images of areas which
A new opportunity can’t be accessed by larger visual
for ScoutCam devices and in harsh
Our visualization environments
solutions fill a need that
current technologies are Applying unique data
not yet providing transmission capabilities
Enabling maintenance and very
early predictive maintenance
capabilities in places otherwise
inaccessible to the human eye
11The truth is in the
eye of the beholder
ScoutCam’s Camera-as-a-SensorTM approach
We take
• Vision is the most important and informative way to
communicate data, for human and machines alike predictive
• ScoutCam’s micro visualization sensors provide a high
maintenance to
resolution image and its analysis a whole new
• Our solutions enable the detection and alert of
level of pre-fault
malfunction before the conventional existing sensors are detection
able to detect it
12Visualization
solutions Super small and Durability and Exceptional data
as never lightweight resilience in diverse
and extreme
transmission
technologies
seen before Camera diameter
> 1mm
conditions
Temperatures: Wireless:
0.04 gram
-127ºC to +100ºC zero latency
High definition and
resolution Waterproof and Wired:
RF protected 30-40m cables,
Unique illumination low data loss
features Resilient to:
Vibrations, Vacuum,
Focal distance – cosmic and ionizing
2 mm radiation
13Multiple view Small diameter video
Strong 42
endoscopes (2001) -
Granted US, Japan,
camera (2010) - Granted
in US and Asia; debated in
Europe Endoscope Europe Camera
IP active with more than one
camera (e.g., oneCreating the base
for future growth
Gaining experience in providing
visualization solutions to major
players in different industries
Full customization - From definition
to design, to planning and full-scale
manufacturing
Prototype production floor capabilities and
processes were established and approved
based on highly-demanding regulatory criteria
(ISO 7/8 clean rooms, testing with 1-micron accuracy, FDA and
CE compliant facilities)
Full in-house assembly & Excellent
cost/performance
15Experienced leadership
Prof. Benad Goldwasser Yovav Sameach
COB CEO
A serial entrepreneur and inventor Senior level executive with extensive
with multiple exits. Board member hands-on experience in leading
of numerous life-science multi-disciplinary and SW
companies. Managed biomedical organizations’ P&L (>$100M) to
investments, and international VCs. sustainable growth and acquisition.
Amir Govrin Prof. Kobi Bortman
CTO BD Industry 4.0
Over 20 years of medical devices Brigadier general (ret.)
R&D experience with more than 30 An expert in material and structure
issued patents. failure mechanisms. Served in the
IDF as the head of the Air Force's
equipment division.
16Premium
Investors
Mori Arkin David Fuhrer Shmuel Dornstein
(Arkin Holdings) (Neopharm) (Rav-Bariach)
Yoram Shimon Prof. Benad
Bauman Sheves Goldwasser
17Cap table
Common Common Stock % Fully
% Warrants
Stock Fully diluted diluted
Medigus Ltd. 16,918,423 44.44% 3,869,699 20,788,122 31.49%
M. Arkin (1999) Ltd. 4,468,367 11.74% 5,862,213 10,330,580 15.65%
Other Investors 16,686,232 43.83% 8,786,127 25,472,359 38.59%
ESOP - Allocated 7,145,186 10.82%
ESOP - Unallocated 2,277,254 3.45%
Total 38,073,022 100.00% 18,518,039 66,013,501 100.00%
18Use of proceeds
10%
Marketing
37% Seeking
Operations $15M
and G&A
53%
R&D
(industry 4.0)
19ScoutCam in
Huge growth Proven, resilient,
a nutshell potential in patent-protected
Charting new “blue ocean”, redefining technologies and
powered by proven existing diverse markets solutions
solutions and revenues
Harvest Attractive
previous investment with
investments Israel's leading
investors
20THANK YOU www.scoutcam.com
You can also read
